SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-009684
Filing Date
2024-03-12
Accepted
2024-03-12 17:05:19
Documents
16
Period of Report
2024-03-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40398
2 ex99-1.htm EX-99.1 16570
3 ex99-1_001.jpg GRAPHIC 3119
  Complete submission text file 0001493152-24-009684.txt   239650

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE imnn-20240306.xsd EX-101.SCH 3009
5 XBRL LABEL FILE imnn-20240306_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE imnn-20240306_pre.xml EX-101.PRE 22355
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3619
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Filer) CIK: 0000749647 (see all company filings)

IRS No.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15911 | Film No.: 24743185
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)